File Download
Supplementary

Conference Paper: In vivo chromium-enhanced MRI of normal and injured retinas

TitleIn vivo chromium-enhanced MRI of normal and injured retinas
Authors
Issue Date2012
PublisherInternational Society of Magnetic Resonance in Medicine.
Citation
The 20th Annual Meeting & Exihibition of the International Society of Magnetic Resonance in Medicine (ISMRM 2012), Melbourne, Australia, 5-11 May 2012. In Proceedings of the 20th ISMRM, 2012, no. 0890 How to Cite?
Abstract
Chromium (Cr) has been used histologically to stabilize lipid fractions in the retina, and is suggested to enhance oxidizable lipids in brain MRI. This study explored the feasibility, sensitivity and specificity of in vivo chromium-enhanced MRI (CrMRI) of retinal lipids, by determining its spatiotemporal profiles and toxic effect after intravitreal Cr(VI) injection to normal and injured adult rats. One day after 3£gL Cr(VI) administration at 1mM to 100mM, the normal retina exhibited a dose-dependent increase in T1-weighted hyperintensity until 50mM. Time-dependently, significant T1-weighted hyperintensity persisted up to 2 weeks after 10mM Cr(VI) administration. While CrMRI demonstrated reduced Cr enhancement in hypoxic-ischemic-injured retina, 3D-CrMRI of ex vivo normal eyes at isotropic 50£gm resolution showed at least 5 alternating bands across retinal layers, with the outermost layer being the brightest. This agreed with histology indicating alternating lipid contents with the highest level in the photoreceptor layer of the outer retina. While Cr(VI) reduction may induce oxidative stress and depolymerize microtubules, manganese-enhanced MRI after CrMRI showed a dose-dependent effect of Cr toxicity on Mn uptake and axonal transport along the visual pathway. These results potentiated longitudinal CrMRI studies on retinal lipid metabolism upon further optimization of Cr doses with visual cell viability.
DescriptionTheme: Adapting MR in a Changing World
Persistent Identifierhttp://hdl.handle.net/10722/165195

 

DC FieldValueLanguage
dc.contributor.authorChan, KCen_US
dc.contributor.authorFan, Sen_US
dc.contributor.authorZhou, IYen_US
dc.contributor.authorWu, EXen_US
dc.date.accessioned2012-09-20T08:16:11Z-
dc.date.available2012-09-20T08:16:11Z-
dc.date.issued2012en_US
dc.identifier.citationThe 20th Annual Meeting & Exihibition of the International Society of Magnetic Resonance in Medicine (ISMRM 2012), Melbourne, Australia, 5-11 May 2012. In Proceedings of the 20th ISMRM, 2012, no. 0890en_US
dc.identifier.urihttp://hdl.handle.net/10722/165195-
dc.descriptionTheme: Adapting MR in a Changing World-
dc.descriptionTraditional Poster Session - Neuro A: Animal Models - Stroke: no. 0890-
dc.description.abstractChromium (Cr) has been used histologically to stabilize lipid fractions in the retina, and is suggested to enhance oxidizable lipids in brain MRI. This study explored the feasibility, sensitivity and specificity of in vivo chromium-enhanced MRI (CrMRI) of retinal lipids, by determining its spatiotemporal profiles and toxic effect after intravitreal Cr(VI) injection to normal and injured adult rats. One day after 3£gL Cr(VI) administration at 1mM to 100mM, the normal retina exhibited a dose-dependent increase in T1-weighted hyperintensity until 50mM. Time-dependently, significant T1-weighted hyperintensity persisted up to 2 weeks after 10mM Cr(VI) administration. While CrMRI demonstrated reduced Cr enhancement in hypoxic-ischemic-injured retina, 3D-CrMRI of ex vivo normal eyes at isotropic 50£gm resolution showed at least 5 alternating bands across retinal layers, with the outermost layer being the brightest. This agreed with histology indicating alternating lipid contents with the highest level in the photoreceptor layer of the outer retina. While Cr(VI) reduction may induce oxidative stress and depolymerize microtubules, manganese-enhanced MRI after CrMRI showed a dose-dependent effect of Cr toxicity on Mn uptake and axonal transport along the visual pathway. These results potentiated longitudinal CrMRI studies on retinal lipid metabolism upon further optimization of Cr doses with visual cell viability.-
dc.languageengen_US
dc.publisherInternational Society of Magnetic Resonance in Medicine.-
dc.relation.ispartofProceedings of the 20th Annual Meeting of the International Society of Magnetic Resonance in Medicine, ISMRM 2012en_US
dc.titleIn vivo chromium-enhanced MRI of normal and injured retinasen_US
dc.typeConference_Paperen_US
dc.identifier.emailFan, S: fanshj08@hkucc.hku.hken_US
dc.identifier.emailZhou, IY: iriszhou@eee.hku.hk-
dc.identifier.emailWu, EX: ewu@eee.hku.hk-
dc.identifier.authorityWu, EX=rp00193en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros207484en_US
dc.publisher.placeAustralia-
dc.description.otherThe 20th Annual Meeting & Exihibition of the International Society of Magnetic Resonance in Medicine (ISMRM 2012), Melbourne, Australia, 5-11 May 2012. In Proceedings of the 20th ISMRM, 2012, no. 0890-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats